Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
53 Leser
Artikel bewerten:
(0)

PharMEDium Announces the Extension of Its Agreement with Novation to Deliver Outsourced Pharmacy Compounding Services

LAKE FOREST, Ill., Jan. 30, 2012 /PRNewswire/ --David N. Jonas, PharMEDium Chairman and CEO, announced the extension of PharMEDium's agreement with Novation through October 2013 to deliver outsourced pharmacy compounding and admixture services. Mr. Jonas commented, "We are committed to being the partner of choice for Novation's outsourced pharmacy compounding and admixture services. PharMEDium and Novation share core values that emphasize patient safety first, facilitate the best clinical care and provide the highest quality sterile intravenous admixture compounding services."

Ross Day, R.Ph., Novation Portfolio Executive, stated,"PharMEDium continues to deliver a proven record of quality, customer service and experience which has been an asset to our organization's contract portfolio. We are pleased to extend our contract with PharMEDium, a reliable leader in this business segment, to deliver the best patient care backed and enhanced by market-leading suppliers."

Novation LLC, based in Irving, Texas, delivers savings to nearly 25,000 VHA Inc. and the University HealthSystem Consortium (UHC)member organizations and 5,500 Provista members covering 28,000 sites. By combining scale and expertise with data-driven tools and information, Novation offers the most extensive range of advanced contracting services in the industry. In 2010, VHA, UHC and Provista members used Novation and alliance contracts to purchase about $40 billion in products and services.

Jennifer Adams, Vice President, Sales, for PharMEDium, stated, "We are proud to announce the continuation of our affiliation with Novation, the industry's premier supply contracting company. We will continue to provide Novation member organizations with quality and reliable outsourced pharmacy compounding and admixture services. We work to ensure that our proven record of quality, customer service and experience continues to be an asset to the Novation organization's contract portfolio. Novation delivers superior patient care and PharMEDium is pleased to be a market-leading supplier selected by Novation to continue providing innovative services their members can rely on."

PharMEDium is the national leading provider of pharmacy sterile intravenous admixture compounding services. The PharMEDium® network of state licensed and federally registered compounding centers provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and federal regulations, including USP Chapter (797), and DEA requirements. For more information on PharMEDium, visit www.pharmedium.com.

SOURCE PharMEDium

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.